TEM's Genomics unit is expected to report strong growth for the first quarter, banking on continued unit growth pick-up.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $63.78, ...

TD Cowen analyst Daniel Brennan maintained a Buy rating on Tempus AI, Inc. Class A (TEM – Research Report) today and set a price target of ...

Tempus AI (TEM) has seen a significant surge on Wednesday, with its stock climbing 14.62% in just one day. The significant boost in TEM stock ...